Landscape of transition of microorganisms to internal organs during the experimantal bacterial translocation
|
|
- Alice Floyd
- 6 years ago
- Views:
Transcription
1 Landscape of transition of microorganisms to internal organs during the experimantal bacterial translocation Table 2. Comparative characteristics of patients main and control group Parameters Main group (n=38) Control group (n=31) Sex male 25 (65,8%) 17 (54,8%) female 13 (34,2%) 14 (45,2%) Age, years 48,9 [42,5 58,7] 48,0 [38,2 53,7] RI, mmhg 143,0 [127,4 173,2] 137,0±18,2 LIS, points 2,6 [2,1 2,91] 2,7 [2,45 3,1] Dynamics of changes in RI are presented in Figure 1. As shown in the graph presented, in patients of the main group respiratory index increased much faster than the control (p <0,05). This suggests that early and mandatory implementation of Recruitment maneuver in patients with ARDS on the background of obesity is already possible to eliminate atelectasis during the 1st day of mechanical ventilation has led to the progressive improvement of oxygenation. Number of days on mechanical ventilation, decreased from 11,1 ± 10,2 to 8,2 ± 3,6 days. The mortality rate decreased from 42% (corresponding to world statistics) to 15.8%. Fig. 1. Dynamics of respiratory index Conclusions Obesity a risk factor for ARDS and severe course in patients with community-acquired pneumonia. Early transfer of patients with bilateral infiltrates on chest radiograph and obesity in the ICU, early non-invasive ventilation and early transfer to mechanical ventilation (translation criteria: PaO 2 /FiO 2 <175 mmhg after 1 hour conducting NIV) c mandatory implementation of maneuver Recruitment can effectively prosthesis lung function in these patients, helping to reduce the duration of mechanical ventilation and decrease mortality. References: 1. Полушин, Ю. С. Вирусная пневмония грипп А (H1N1), осложненная ОРДС/Ю. С. Полушин [и др.]//общая реаниматология С Чучалин, А. Г. Грипп: уроки пандемии//пульмонология. Приложение: «Грипп А/H1N1: уроки пандемии» С Incidence and outcomes of acute lung injury/g. D. Rubenfeld [et al.]//n Engl J Med Vol P Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time/M. Zambon, J.-L. Vincent//Chest Vol P Светлицкая, О. И. Острое повреждение легких у пациентов с вирусно-бактериальной пневмонией на фоне избыточной массы тела и ожирения/о. И. Светлицкая, И. И. Канус//Медицинские новости С Body mass index is associated with the development of acute respiratory distress syndrome/m. N. Gong [et al.]//thorax Vol. 65. P Suwonov Qayim Jahonovich, PhD, Senior scientific employee-researcher, Research Institute of Sanitation, Hygiene and Occupational Diseases Ministry of Health of Uzbekistan, Landscape of transition of microorganisms to internal organs during the experimantal bacterial translocation Abstract: The purpose of the scientific work was study of the landscape of microorga-nisms grown (LMG) from the internal organs of laboratory animals in experimental acute obstru-ction of the small (EAOSI) and large intestine (EAOLI). It has been established that Gram-ne-gative sticks, Gram-positive cocci and anaerobes were identified in the experimental model EAOSI. Anaerobic translocation low level of ability. With the increase in the duration of mic-roorganisms translocation (MT) the shutter all the members are equally spread. EAOSI there is a big difference between the recovered Staphylococcus spp and Enterococcus spp recognized as one of the main microbiological criteria. Keywords: experimental obstruction, the small intestine, the large intestine, landscape of microorganisms, bacterial translocation, Gram-positive cocci. 137
2 Section 7. Medical science As you know, representatives of the normal microflora of the human large intestine in-digen and facultative organisms with balance disorders (dysbiosis), with an increase of permea-bility through the mucous membrane of the intestine, would be increased passage of viable mic-roorganisms in a variety of internal organs through the blood and lymph. Bacterial translo-cation (BT) this state, along with the name of microorganisms passing on these organs is called MT [2; 9; 10; 11]. There are different opinions about the importance of this phenomenon: the first suppor-ters consider it one of the pathogenetic links of various diseases [1; 3; 7], while others will inter-pret this as a factor in protecting the organism [4; 6]. Taking into account the usefulness of the experimental studies, we started it. Purpose of the work. The study and evaluation of the LMG from the internal organs of laboratory animals in (EAOSI) and (EAOLI). Materials and methods. During implementation of our scientific research work, we strictly followed the biosecurity rules and principles of ethics in work with experimental material. A total of 368 surveys, white, wild mice, weighing 25 grams and higher, the age of 2 3 months. Feeding and care of laboratory animals, division into groups and preparation those for the experiments were carried out in the traditional methods. We used an experimental model EAOS and EAOLI with the introduction of our modifi-cations proposed by Kruglyanskiy Y. M. [5] in the formation of an EAOS and EAOLI. Conducted 3 series of research work. All laboratory animals divided into 4 groups: Group 1 EAO- SI, n=72; Group 2 EAOC, n=72; Group 3 animals, which were opened in the abdominal cavity, but not performed obtu-ration (group comparisons, n=72); Group 4 intact laboratory animals (control group, n= 24). In turn, 1, 2 groups were divided into subgroups: 1a, 2a EAOSI EAOC and lasted 24 hours (n=8); 1b, 2b EAOSI and EAOC, lasted for 48 hours (n=8); 1c, 2c EAO- SI and EAOK, lasted for 72 hours (n=8). These deadlines are selected as a result of the wall of the intestine obstruction mainly according to the pathological, morphological, clinical changes [3; 5]. Advanced bacteriological study was carried out with respect to microorganisms grown from the internal organs of laboratory animals. Identification and differentiation of the seeded microorganisms carried out by Bergey s [8]. To do this, the nutritional resources of the company «HiMedia» (India) were used. Statistical analysis of results of biomedical research were carried out on the personal computers with processor Pentium 4, using Excel special program. Results and discussion. According to the deadlines of the experiment, LMG from the mesenteric lymph nodes (MLN) in the experimental model EAOSI were different. Among all st-rains, Escherichia spp were most common. Particularly attracted the attention that the 24 and 48 hours of experience was grown only Escherichia spp (n=10 and n=7, respectively) as a mono-culture.after formation of EAOSI, grown Gram-negative (Enterobacter spp, Citrobacter spp, Proteus spp), Gram-positive (Staphylococcus spp, Enterococcus spp) and anaerobes (Bacteroides spp) as a monoculture not have been grown from the MLN of used laboratory animals. The association of microorganisms has got a different situation. Although the experience of leadership in quantitative terms even if it is still owned by Escherichia spp (з<0.001) was observed in other microorganisms rawled. If after 24 hours in strains of microorganisms in the form of the association of sprouts 45.6 ± 7.3% (n=21), Escherichia spp, here in after referred to as Proteus spp (17.4 ± 5.6%, n=8), Enterobacter spp (15.2 ± 5.3%, n=7), Staphylococcus spp (10.9 ± 4.6%, n=5), Citrobacter spp (8.7 ± 4.2%, n=4), Enterococcus spp (2.2 ± 2.1%, n=1). Bacteroides spp as monocultures and associations have not been grown. After obturation, 48 hours later, growth of microorganisms increased in amount, but it remained similar to the above tendency. According to the the division of interest was as follows: Escherichia spp 47.4 ± 4.6% (n=55), Proteus spp 26.7 ± 4.1% (n=31), Enterobacter spp 8.6 ± 2.6% (n=10), Staphylococcus spp 7.8 ± 2.5% (n=9), Citrobacter spp 6.7 ± 1.8% (n=9), Enteroco-ccus spp 0.9 ± 0.8% (n=1). Experience the next term (72 hours) quantitative microorganisms along with the more detached from their ratio to one another also changed. Proteus spp, Escherichia spp on the redu-ced rate of other microorganisms on a significant scale has not changed. 72 hours, depending on the level of MT in the following sequence: Escherichia spp (36.6 ± 4.2%, n=48), Proteus spp (21.4 ± 3.6%, n=28), Enterobacter spp (16.0 ± 3.2%, n=21), Staphylococcus spp (12.2 ± 2.9%, n=16), Citrobacter spp (11.8 ± 2.7%, n=16), Enterococcus spp (0.8 ± 0.7%, n=1), Bacteroides spp (0,9 ± 0,6%, n=1). It is noteworthy that, irrespective of the length of experience did not change the amount of Enterococcus spp, and Bacteroides spp. We believe that this EAOSI MT rate is low, it means that translocations ability and the ability of other Gram-sticks low against Gram-positive cocci. The evaluation of the intensity of BT EAOSI pathogenetic mechanism is based on the formation of an experimental model of EAOSI that this situation should be taken into account. Experimental model EAOSI MLN has grown compared to the corresponding period of microorganisms (Figure 1) percent of strains of Escherichia spp other increases decreased with increasing duration of the experience. We believe that this form of association due to other microorganisms. Experimental model EAOSI obturation the next 24, 48, 72 hours microorganisms rawled MLN from a lot of different changes in the liver retained. Liver only form of monoculture, Escherichia spp collected: 9 strain after 24 hours, 48 hours, 12 stamps, and 72 hours after 9 stamps. Other microorganisms only in the form of associations failed. Escherichia spp, 24 hours later, all the grown strains of 50.0 ± 10.2% (n=12), 48 hours after it was 43.1 ± 6.5% (n=25), 72 hours after the 47.5 ± 5.0% (n=47), respectively. Common interest between the difference is not statis-tically reliable (р>0.05). Thus, the level of Escherichia spp met in the increase of the amount, depending on the duration of the experiment thought about it, measured in relation to the other microorganisms. After 24 hours, Proteus spp and Staphylococcus spp respectively 16.7 ± 7.6% (n=4) and 20.8 ± 8.3% (n=5), established, 48, and 72 hours after they are respectively were as follows: 27.6 ± 5.9% (n=16), 12.1 ± 4.3% (n=7) and 20.2 ± 4.0% (n=20), 11.1 ± 3.2% (n=11). Enterobacteria (Enterobacter spp, Citrobacter spp), along with the number of microorganisms as defined above, interest rates can not compete. Enterococcus spp, and Bacteroides spp MLN parameters were similar results, that is, detecting significant changes in the risks associated with a period of EAOSI and reliable. The results also differ in terms of the number of microorganisms on the divorce, or a ratio of one significant difference was detected. This member received compensation in the form of monoculture, mainly Escherichia spp. Identification of these microorganisms in the 138
3 Landscape of transition of microorganisms to internal organs during the experimantal bacterial translocation form of the association are the advantages clearly visible. 48 hours after the аssociation s stamp form of 20 and 9 (45.0 ± 11.1%), which is owned by Escherichia spp, 5 (25.0 ± 9.7%), Staphylococcus spp, and 4 (20.0 ± 8.9%), Proteus spp, and 2 (10.0 ± 6.7%), Enterobacter spp. The rest of the microor-ganism (Citrobacter spp, Enterococcus spp, Bacteroides spp) identified this term. This trend re-mained after 72 hours. Treeless Citrobacter spp (9.1 ± 6.1%, n = 2), Enterococcus spp (4.5 ± 4.4%) were identified. Figure 1. Experimental EAOSI MLN of the results of the study, compared to the corres-ponding period of sprouts and microorganisms,% Lungs seedling also done a lot of Escherichia spp charged with distinction. Due to a lack of statistical analysis of the number of strains collected, we find it necessary to comment on all the numbers, but the trend of the previous commented exchange want to admit the rest. Research at the next stage of our game was similar to the above research. Experimental model MLN strains of microorganisms from EAOSI to germinate, such as Escherichia spp. 24 hours later after obturation monoculture 6 stamp detached, the association is in the form of 23 stamps. This form of association for all strains of microorganisms to 47.9 ± 7.2%, respectively. Followed by Enterococcus spp (14.6 ± 7.2%, n=7), Proteus spp (12.5 ± 4.8%, n=6), Enterobacter spp (12.5 ± 4.8%, n=6), Citrobacter spp (8.3 ± 4.0%, n=4), Staphylococcus spp (4.2 ± 2.9%, n=2) busy. This term has not been identified Bacteroides spp. The main difference from the experimental EAOSI Enterococcus spp s a lot to be identified. 48 hours later a changed ratio of microorganisms. This term Escherichia spp (45.6 ± 5.6%, n=36), followed by Proteus spp (15.2 ± 4.0%, n=12), Enterobacter spp (12.7 ± 3.8% n=10) respectively. Other strains of Enterococcus spp slightly less (11.4 ± 3.6%, n=9) were collected. It is run pilot EAOSI less than the total number of strains, compared with 1.5 times (116 stamps 79 stamps) have been identified. 72 hours after the results are a little different, if EAOSI at the same time from the as-sociation, a total of 131 in the form of stamp collection, at 1.2 times this figure (160 strain). Es-cherichia spp, the total number of strains from 38.1 ± 3.8% (n=61), respectively. Lack of reliable compared to the previous terms of this indicator (P <0.05) after 72 hours of Enterococcus spp (17.5 ± 3.0%, n=28). Each model offers 72 hours after the results of the comparative study of the landscape of the MLN has grown microbes in Figure 2. Figure 2. Experimental EAOSI and 72 hours later after the obturation in the EAOSI, MLN of the microbes collected from the landscape, % 139
4 Section 7. Medical science Figure 2 shows that both views of the model identified by microorganisms in the form of association clearly shows differences in the level of invention. In each case, the intensity of BT leading difficult to distinguish microorganisms. Results of experimental liver has LMG MLN figures are similar. At the same time, micromonocultural concerning the association found that only 24 and 48 hours respectively 3 (Escherichia spp) and 5 (Escherichia spp) case.as the leadership of the association, in the form of MLN Escherichia spp. Escherichia spp 24 hours after 50.0 ± 11.2% (n = 10) identified in the case, other microorganisms (Proteus spp, and Enterobacter spp, Citrobacter spp, Enterococcus spp), 50.0 ± 11.2%. Unlike EAOSI not identify Staphylococcus spp. 48 hours after the results were completely different, the leadership is still Escherichia spp (46.7 ± 6.4%), followed by Enterococcus spp 25.0 ± 5.6%, n=15) and Proteus spp (15.0 ± 4.6%, n=9) out. These results suggest that changes in the parameters of the EAOSI trend similar to that of the case (58 stamps of 60 stamps), were differences in the ratio of one of the microorganisms. If EAOSI Proteus spp 27.6 ± 5.9% (n=15), Staphylococcus spp 12.1 ± 4.3% (n=7), Enterococcus spp 3.4 ± 2.4% (n=2) is charged, this is one of the parameters of a credible difference (р<0.05) respectively 15.0 ± 4.6% (n=9), 3.3 ± 2.3% (n=2) and 25.0 ± 5.6% (n=15) (Figure 3). 140 Figure 3. Experimental EAOSI and after the obturation 48% of the liver has LMG Experience the next term (72 hours), the number has grown strains compared to the previous period to 2.0 times (119 stamps 60 stamps).the percentage of microorganisms different from each other, positive results have been obtained. At the same time, Escherichia spp liver microorganisms him after 48.7 ± 4.6%, respectively. This option MLN has grown Escherichia spp, which is more than 1.3 times the amount of reliable, EAOSI index (p>0.05). At the same time Enterobacter spp (6.7 ± 2.3%, n = 8), Citrobacter spp (5.9 ± 2.2%, n=7), Proteus spp (16.8 ± 3.4%, n=20), Bacteroides spp (1.7 ± 1.2%, n=2) compared to the same pe-riod of the indicators EAOSI whether significant difference (р>0.05), Staphylococcus spp (1.7 ± 1.2% and 11.1 ± 3.2%) and Enterococcus spp (18.5 ± 3.8% and 2.0 ± 1.4%) on the parameters of the difference was significant (р<0.001). Identification of a spleen is also dominated by the amount of microorganisms Escherichia spp, and 48 hours later in the form of the Association charged him 7 of 14 stamps. Enterobacter spp, Citrobacter spp, Staphylococcus spp not identified, but even if it is less than 72 hours after their rawled. 48 and 72 hours in other strains of Proteus spp and Enterococcus spp significantly greater in the head. Thus, the increase in the number of Enterococcus spp can be seen as a remar-kable situation. MLN results obtained from the lungs, liver and spleen variables are no similar laws simi-lar trend Escherichia spp other microorganisms to germinate.due to a lack of statistical analysis of the number of strains collected from all found that the numbers are interpreted in an illegal. Conclusions. 1. It has been established that Gram-negative sticks, Gram-positive cocci and anaerobes were identified in the experimental model EAOSI. Experience all the time (24, 48, 72 hours), the amount of Escherichia spp other strains ½ part. Across all strains ¾ enterobacteria. The ability to translocation against Gram-negative bacteria are Gram-positive cocci 3 4 times higher. 2. Anaerobic (Bacteroides spp) tranlocation low level of ability and experience with in the quantitative aspects of change. 3. All members of the growing MT the shutter time in a uniform distribution, and all indicators MLN clearly seen in the liver, spleen, and in particular the lungs, the microorganisms in the form of monoculture and association met thought about it, was not evident in the intensity of BT. 4. Experimental model of EAOSI LMG MLN been identified by credible distinction, which is, first of all characterized by an increase in the number of strains allocated 2.0 times, second 48, and 72 hours later, Enterococcus spp, Escherichia spp put to the next problem. 5. Experimental EAOSI there is a big difference between the recovered Staphylococcus spp and Enterococcus spp recognized as one of the main microbiological criteria. References: 1. Almagambetov K. K., Bondarenko V. M. Simulation of translocation of intestinal microflora on conventional animals//medical journal Moscow, 1991; 8: (In Russian). 2. Galeev Y.M, Popov M. V., Salato O. V. Methods of study of the propagation of bacterial cells//siberian Journal of Medicine. Irkutsk, 2011; 3: (In Russian). 3. Gostishchev A. N. Afanasiev Y. M. Kruglyanskiy D. N., Sotnikov V. K. Bacterial translocation in acute intestinal obstruction//journal of Medical Sciences Moscow, 2006; 9 10: (In Russian).
5 Using immunocorrection therapy in patients with chronic pancreatitis 4. Gritsenko VA Properties of E. coli isolated from mice with bacterial translocation after im-mobilization stress//medical journal Moscow), 2000; 2: (In Russian). 5. Kruglyanskiy Y. M. Bacterial translocation with obstructive ileus (experimental research): Abstract. Dis. cand. med. sciences. Moscow, 2007; 24 p. 6. Nikitenko V. I., Tkachenko E. I., Stadnikov A. A. Translocation of bacteria from the gast-rointestinal tract a natural defense mechanism//experimental and clinical gastroenterology Moscow, 2004; 1: (In Russian). 7. Nurmukhamedov H. K. Bacterial translocation in infectious-toxic shock in infants//infection, immunity and pharmacology Tashkent, 2004; 1: (In Russian). 8. The determinant of bacteria Burgi. Edited by J. Holt, N. Krieg, Sneath P., J. Staley, Williams C. Moscow: Mir. 1997; Vol Ergashev V. A., Nuraliev N. A. The phenomenon of bacterial translocation and location of microorganisms in its formation//infection, immunity and pharmacology Tashkent, 2014; 3 (2): (In Russian). 10. Berg R. D., Garlington A. W. Translocaision of certain indigenous bacteria form the gastroin-testinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model//infection and immunology, 1979; 23 (2): Berg R. D. Bacterial translocation from the intestines//jikken Dobutsu, 1985; 34 (1): Suleymanov Suleyman Fayzullaevich, PhD, Senior Researcher, Head of the Chair of Microbiology and Phthisiology of the Bukhara State Medical Institute, Bukhara, Uzbekistan E mail: ss 1961@mail.ru Using immunocorrection therapy in patients with chronic pancreatitis Abstract: The immune system studied in 36 patients with chronic pancreatitis (CP) and 32 healthy individuals. In patients with CP showed a deficiency of T lymphocytes and subset tension humoral immunity and cytokine profile. Using Thymoptinum (dose of mg per course) in conjunction with conventional treatment in patients with CP led to an increase in cellular immunity and stabilization of cytokine levels. Keywords: the immune system, T and B link immunity, cellular immunity, humoral immunity, link, immunotherapy, pancreatitis. Changes in the environment, technology, food industry, lifestyle and spreading western food are the reason of growing the diseases of the pancreas. Over the past 30 years, marked by the global trend to an increasing in the incidence of acute and chronic pancreatitis (CP) is more than 2 times [2; 3; 10]. CP prevalence, increasing morbidity and temporary disability due to disability is an important social and economic problem of modern medicine. In the structure of morbidity gastrointestinal organs CP is from 5.1 to 9%, and in general clinical practice from 0.2 to 0.6% [3, 5 7; 12]. Inflammation in the pancreas can develop due to malfunction of the immune system, which are based on allergic reactions, as well as response to bacterial factor [1; 5; 8]. However, immune disorders and their correction in patients with CP are still poorly studied to the present time. The purpose of the work studying of the immune system parameters and conduct immunocorrecting treatment in patients with CP. Materials and methods. 36 patients were examined (33 65 ages) with a diagnosis of CP. The diagnosis was carried out on the basis of complaints, medical history, and objective laboratory tests, instrumental data: ultrasound, fibrogastroduodenoscopy, survey radiography of abdominal organs. The control group consisted of donors from 32 healthy subjects (25 55 ages). The concentration of serum immunoglobulins (SI) classes A, M and G were determined by radial immunodiffusion (Mancini G., 1965). The parameters of cellular immunity (T lymphocytes and a subpopulation, B lympho-cytes) were identified using monoclonal antibodies (LLC Sorbent Service, Russia) [4]. Quanti-fication of levels TNF-a, IL 6, IL 4 in serum performed using reagents set ProCon (LLC Protein contour, St. Petersburg) by ELISA. Immunotherapy was carried out in 15 patients. Thymoptinum (Uzbekistan) was used as an Immunological drug mg per treatment (dose 100 mg/day for 8 10 days). The indicators of immunity was studied twice: before and after 1 month after treatment). Results and discussion. In patients with CP found immunodeficiency cell component: 0.7 times whatever suppression of the total lymphocyte pool T (CD3) 35.3 ± 2.6% as compared with the control group 52.4 ± 1.8% (p<0.001); 0.8 fold decrease in the absolute number of T (CD3)-cells (p<0.05). Also determined the oppression subpopulations of T lymphocytes, have the helper-suppressor function Th (CD4) 29.5 ± 1.1% (p <0.001) and ± 32.1 cells/1 mcl blood (p<0.001) (control in 36.5% ± 0.7 and ± 44.3 cells/1 mcl of blood, respectively), the contents of Ts (CD8) 13.8 ± 1.4% (p<0.05) and ± 9.8 cells/1 mcl blood (p<0.01) On the side of B (CD19) cell link, opposite, the tendency to increase as the relative parameter 20.6 ± 2.3% (p<0.05), which was 1.4 times higher than those of the control group values, such and totally 1.7 fold increasing ± 33.4 cells/1 mcl of blood (in the control ± 26.7 cells/1 mcl of blood). An appreciable activation of B cell immunity against the background suppression of T cells in CP reflected in the SI spectrum. For example, attention is drawn to the increasing in IgA production to 3.97 ± 0.41 g/l (p<0.05), which may be a reflection of the organism immune adjustment CP patients in response to enzymatic intoxication. It was found authentically a high content of IgG ± 0.75 g/l (p<0.001) (in control of 15.9 ± 0.94 g/l). IgM concentra- 141
Mastitis: Background, Management and Control
New York State Cattle Health Assurance Program Mastitis Module Mastitis: Background, Management and Control Introduction Mastitis remains one of the most costly diseases of dairy cattle in the US despite
More informationClinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC
Clinical Policy: (Cleocin) Reference Number: CP.HNMC.08 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationTherapeutic apheresis in veterinary
Therapeutic apheresis in veterinary 1 I.P.Pavlov First St.-Petersburg State Medical University, Saint-Petersburg, Russia. Voinov V.A. A. By types of animals on the basis of anatomical and physiological
More informationgingivitis: periodontitis: dental caries: palatinitis: oral pharyngitis and tonsillitis: mouth abscess: glossitis: oro-sinus fistula: gingivitis:
ABSTRACT Mouth is one of the anatomical segments of the digestive microbiota which is characterized by a marked diversity. Among the multitude of microorganisms that inhabit the oral mucosa at a time,
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationRandomized Controlled Trial on Adjunctive Lavage for Severe Peritoneal Dialysis- Related Peritonitis
Randomized Controlled Trial on Adjunctive Lavage for Severe Peritoneal Dialysis- Related Peritonitis Steve SM Wong Alice Ho Miu Ling Nethersole Hospital Background PD peritonitis is a major cause of PD
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationAcute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs
Acute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs No dog parent wants to clean up diarrhea. Cleaning up bloody diarrhea is even more unpleasant. Unfortunately, the development
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationIDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA
page 1 / 5 page 2 / 5 idsa guidelines community acquired pdf IDSA/ATS Guidelines for CAP in Adults CID 2007:44 (Suppl 2) S29 such as blood and sputum cultures. Conversely, these cultures may have a major
More informationCourse: Microbiology in Health and Disease
SYLLABUS BIOL 2900 SECTION D SPRING 2012 Course: Microbiology in Health and Disease BIPIN PATEL Office Hours: Before or after Class or by appointment Semester Begins JANUARY 09 TO MAY 04 2012 2900 D 4.00
More informationCourse: Microbiology in Health and Disease Office Hours: Before or after Class or by appointment
SYLLABUS BIOL 2900 SECTIONS C AND D Spring, 2011 Course: Microbiology in Health and Disease Office Hours: Before or after Class or by appointment Semester Begins on January 10, 2011 and ends on May 2,
More informationImpact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital
Impact of Antimicrobial Resistance on Human Health Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital AMR in Foodchain Conference, UCD, Dec 2014 Sir Patrick Dun s Hospital
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationSuitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)
STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.
More informationAUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS. Sample Exam Questions. Veterinary Practice (Small Animal)
AUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS Sample Exam Questions Veterinary Practice (Small Animal) Written Examination (Component 1) Written Paper 1 (two hours): Principles of Veterinary
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More information12 TIPS HOW TO TREAT BACTERIAL INFECTION WITHOUT ANTIBIOTICS
PDF STD FACTS - BACTERIAL VAGINOSIS 12 TIPS HOW TO TREAT BACTERIAL INFECTION WITHOUT ANTIBIOTICS 1 / 6 2 / 6 3 / 6 bacterial infection close pdf Bacterial vaginosis (BV) is a condition that happens when
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationCritical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary
Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical
More informationVETERINARY MEDICINE-VM (VM)
Veterinary Medicine-VM (VM) 1 VETERINARY MEDICINE-VM (VM) Courses VM 603 Veterinary Science: Research and Methods Credit: 1 (1-0-0) Course Description: Conduct of responsible research, contributions of
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationAntibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco
Antibacterial Resistance: Research Efforts Henry F. Chambers, MD Professor of Medicine University of California San Francisco Resistance Resistance Dose-Response Curve Antibiotic Exposure Anti-Resistance
More informationApproved by the Food Safety Commission on September 30, 2004
Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food
More informationOPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationKey words: Urinary tract infection, Antibiotic resistance, E.coli.
Original article MICROBIOLOGICAL STUDY OF URINE ISOLATES IN OUT PATIENTS AND ITS RESISTANCE PATTERN AT A TERTIARY CARE HOSPITAL IN KANPUR. R.Sujatha 1,Deepak S 2, Nidhi P 3, Vaishali S 2, Dilshad K 2 1.
More informationObjectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017
Basic Microbiology Vaneet Arora, MD MPH D(ABMM) FCCM Associate Director of Clinical Microbiology, UK HealthCare Assistant Professor, Department of Pathology and Laboratory Medicine University of Kentucky
More informationPathogenesis and treatment of feline lower urinary tract disease
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Pathogenesis and treatment of feline lower urinary tract disease Author : Sarah Caney Categories : RVNs Date : May 1, 2011
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationMicrobial landscape of surgical hospital. Biology and Medicine
eissn: 09748369 Microbial landscape of surgical hospital Biology and Medicine Research Article Volume 6, Issue 4, Article ID: BM-058-14, 2014 Indexed by Scopus (Elsevier) www.biolmedonline.com Microbial
More informationBurn Infection & Laboratory Diagnosis
Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die
More informationOverview of Infection Control and Prevention
Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh
More informationBIOL 2900 D 4.00 Microbiology in Health/Disease
SYLLABUS BIOL 2900 - D Spring, 2017 Course: Microbiology in Health and Disease Instructor: Prafull C. Shah Office Hours: Before or after classes, or by appointment by Email to pcshah@valdosta.edu. Semester
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationImportance of Frequency Homeopathic application
Homeopathic Antibiotic for Pets 5 Pages PRODUCT CODE AN070 * Stronger Antibiotic - see product AN071 Infection Fighter 50ml (herbal antibiotic) Last Updated: 11-07-18 All species and ages (and humans)
More informationETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
More informationSHC Clinical Pathway: HAP/VAP Flowchart
SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal
More informationPneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC
Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW
More informationPharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE
Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:
More informationMastitis and colostrum management update. Dr Kiro Petrovski University of Adelaide, Roseworthy
Mastitis and colostrum management update Dr Kiro Petrovski University of Adelaide, Roseworthy Biography Started working with dairy cows at age of 11 First independent calving First cow surgery at 16 Work
More informationClostridium difficile Colitis
Update on Clostridium difficile Colitis Fredrick M. Abrahamian, D.O., FACEP Associate Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA
More informationENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis
GDR11136 ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis February 2012 Summary The challenge data presented in this technical bulletin was completed
More informationEXCEDE Sterile Suspension
VIAL LABEL MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS FOR ANIMAL TREATMENT ONLY EXCEDE Sterile Suspension 200 mg/ml CEFTIOFUR as Ceftiofur Crystalline Free
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationBacterial Pneumonia in Sheep, The Domestic Bighorn Sheep Interface, and Research at ADRU
Bacterial Pneumonia in Sheep, The Domestic Bighorn Sheep Interface, and Research at ADRU USAHA Committee on Sheep and Goats Providence, RI October 27, 2015 PLC M. A. Highland, DVM, DACVP, PhD candidate
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationNIAA Resolutions Bovine Committee
2016-2017 NIAA Resolutions Bovine Committee Mission: To bring the dairy cattle and beef cattle industries together for implementation and development of programs that assure the health and welfare of our
More informationamoxycillin/clavulanate vs placebo in the prevention of infection after animal
Archives of Emergency Medicine, 1989, 6, 251-256 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites P. H. BRAKENBURY & C. MUWANGA Accident
More informationComparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia
Comparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia MH Nguyen, W Pasculle, PG Pappas, G Alangaden, G Pankey, B Schmitt, M Weinstein, R Widen, D
More informationCHAPTER 1 INTRODUCTION
1 CHAPTER 1 INTRODUCTION The Staphylococci are a group of Gram-positive bacteria, 14 species are known to cause human infections but the vast majority of infections are caused by only three of them. They
More informationRole of Anaerobic Flora in the Translocation of Aerobic and Facultatively Anaerobic Intestinal Bacteria
INFECTION AND IMMUNITY, Nov. 1987, p. 2689-2694 0019-9567/87/112689-06$02.00/0 Copyright 1987, American Society for Microbiology Vol. 55, No. 11 Role of Anaerobic Flora in the Translocation of Aerobic
More informationMASTITIS. Therefore, mastitis is an inflammation of the mammary gland.
MASTITIS Mastos = breast itis = inflammation Therefore, mastitis is an inflammation of the mammary gland. Or Reaction to a tissue injury. Therefore, inflammation can and does result in the loss of function
More informationDeveloping practical solutions for sustainable agriculture. Ruth Clements FAI Farms Ltd
Developing practical solutions for sustainable agriculture Ruth Clements FAI Farms Ltd Lameness Reduction Program At FAI we operate a range of fully integrated, commercially viable and animal welfare focused
More informationReduce the risk of recurrence Clear bacterial infections fast and thoroughly
Reduce the risk of recurrence Clear bacterial infections fast and thoroughly Clearly advanced 140916_Print-Detailer_Englisch_V2_BAH-05-01-14-003_RZ.indd 1 23.09.14 16:59 In bacterial infections, bacteriological
More informationAVIAN PROBIOTIC AVI-CULTURE-2 REDUCES NEONATAL MORTALITY AND HELPS TO IMPROVE BREEDING PERFORMANCE DGTDVM-2012 by Dr Gianluca Todisco, DVM, PhD Italy
AVIAN PROBIOTIC AVI-CULTURE-2 REDUCES NEONATAL MORTALITY AND HELPS TO IMPROVE BREEDING PERFORMANCE DGTDVM-2012 by Dr Gianluca Todisco, DVM, PhD Italy www.todvet.it The study was conducted during the 2012
More informationHumane EndPoints (HEP)
Humane EndPoints (HEP) aurora brønstad - university of bergen Definition of HEP OECD: A humane endpoint can be defined as the earliest indicator in an animal experiment of severe pain, distress, suffering
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More informationNational Research Center
National Research Center Update of immunodiagnosis of cystic echinococcosis cysts Global distribution of zoonotic strains of Echinococcus granulosus (Adapted from Eckert and Deplazes, 2004) Echinococcus
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationCLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:
CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by
More informationGuidelines for Laboratory Verification of Performance of the FilmArray BCID System
Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory
More informationGuidelines on prescribing antibiotics. For physicians and others in Denmark
Guidelines on prescribing antibiotics 2013 For physicians and others in Denmark Guidelines on prescribing antibiotics For physicians and others in Denmark 2013 by the Danish Health and Medicines Authority.
More informationCourse Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine
Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine The Master Degree in Internal Medicine/Faculty of Veterinary Medicine is awarded by the Faculty of Graduate Studies
More informationFederal Service for Veterinary and Phytosanitary Surveillance
Federal Service for Veterinary and Phytosanitary Surveillance Food safety Safety standards Laboratory control of production process Veterinary sanitary expertise (VSE) of slaughter products Food safety
More informationLIFELONG CARE PLAN FELINE
LIFELONG CARE PLAN FELINE Your pet is unique, and our veterinarian s treatment plan will be tailored to their specific needs. As your pet grows, however, there are certain health concerns associated with
More informationCourse Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine
Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine The Master Degree in Poultry Diseases /Veterinary Medicine, is awarded by the Faculty of Graduate Studies at Jordan University
More informationSimplicef is Used to Treat Animals with Skin Infections
Simplicef is Used to Treat Animals with Skin Infections PRODUCT INFO Simplicef tablets are a semi-synthetic cephalosporin antibiotic cefpodoxime proxetil used to cure infections caused by the susceptible
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal viscera, examination of, in investigation of emerging infectious diseases of food animals, 6 American Veterinary Medical Association,
More informationThe Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University
The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationPharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J Record Status This is a critical abstract of an economic evaluation
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationSyllabus 2018/2019. Description of the course MICROBIOLOGY (1) Year of studies II Semester Winter X Summer. Laboratory Classes (LC)
Lectures (L) Seminars (SE) Auditorium (AC) Major Classes not clinical (MC) Clinical Classes (CC) Laboratory Classes (LC) Classes in Simulated Conditions (CSC) Practical Classes with Patient (PCP) Specialist
More informationMilk quality & mastitis - troubleshooting, control program
Milk quality & mastitis - troubleshooting, control program Jim Reynolds, DVM, MPVM University of California, Davis Tulare Veterinary Medicine Teaching and Research Center 18830 Road 112 Tulare, CA 93274
More informationAntimicrobial resistance at different levels of health-care services in Nepal
Antimicrobial resistance at different levels of health-care services in Nepal K K Kafle* and BM Pokhrel** Abstract Infectious diseases are major health problems in Nepal. Antimicrobial resistance (AMR)
More informationMARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS
MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL 10%, solution for injection for cattle and swine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Marbofloxacin...100.0
More informationE-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK
15 November, 2017 E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK Document Filetype: PDF 475.49 KB 0 E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK Communicable diseases, also known as infectious diseases or
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationOverview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals
Bacteria Overview Bacteria live almost everywhere. Most are microscopic ranging from 0.5 5 m in size, and unicellular. They have a variety of shapes when viewed under a microscope, most commonly: Spheres,
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationTECHNICAL BULLETIN Claude Toudic Broiler Specialist June 2006
Evaluating uniformity in broilers factors affecting variation During a technical visit to a broiler farm the topic of uniformity is generally assessed visually and subjectively, as to do the job properly
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationAntibacterials. Recent data on linezolid and daptomycin
Antibacterials Recent data on linezolid and daptomycin Patricia Muñoz, MD. Ph.D. (pmunoz@micro.hggm.es) Hospital General Universitario Gregorio Marañón Universidad Complutense de Madrid. 1 GESITRA Reasons
More information